Showing results (11-20 of 94) with videos related to
Sort By:
Pageof 10
Health and Quality of Life Outcomes|June 18, 2020
Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumoursHalfdan Sorbye, Liv Sylvi Meyer, Kjersti Elisabeth Mordal, et al.Acta Oncologica (Stockholm, Sweden)|January 20, 2015
Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?Laurids Ø Poulsen, Camilla Qvortrup, Per Pfeiffer, et al.Journal of Pediatric Hematology/Oncology|October 28, 2011
Small cell lung cancer in a 14-year-old girlHåvard Trønnes, Hans Kristian Haugland, Albert N Békássy, et al.BMC Cancer|August 18, 2017
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9Stine Braendegaard Winther, Pia Österlund, Åke Berglund, et al.Scientific Reports|July 2, 2020
Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3Abir Salwa Ali, Aurel Perren, Cecilia Lindskog, et al.Endocrine-Related Cancer|January 11, 2023
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohortDimitrios Papantoniou, Malin Grönberg, Espen Thiis-Evensen, et al.Endocrinology, Diabetes & Metabolism Case Reports|November 30, 2021
Feminizing adrenal tumor identified by plasma steroid profilingElinor Chelsom Vogt, Kathrin Hammerling, Halfdan Sorbye, et al.Cancer|June 30, 2009
Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patientsHalfdan Sorbye, Per Pfeiffer, Nina Cavalli-Björkman, et al.International Journal of Cancer|March 19, 2016
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastasesInger Marie Løes, Heike Immervoll, Halfdan Sorbye, et al.World Journal of Surgical Oncology|December 4, 2015
Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastasesJon-Helge Angelsen, Asgaut Viste, Inger Marie Løes, et al.Pageof 10